If you are:
FDB Only When Necessary: AVAIL DATA NO KNOWN RISK FOR DEVELOPMENTAL TOXICITY AFTER INADVERTENT EXPOSURE
Precaution: MAY DECREASE MILK PRODUCTION, USE LOWEST DOSE
Precaution: INSUFFICIENT DATA AVAILABLE; PROGESTINS ARE EXCRETED
An adult over 60:
management or monitoring precaution: General-Use lowest possible dose for shortest duration and in combination with a progestin as indicated to reduce the risk of endometrial hyperplasia and breast cancer. Cardiovascular-May increase risk for thromboembolic events. Avoid use in patients with known, suspected, or history of arterial or venous thromboembolic disease. Neuro/Psych-May increase the risk for dementia.
Giving Mononessa to a child under 12:
Severe Precaution: Not indicated before menarche.